Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Acupressure therapeutic care improves fatigue in breast cancer patients on chemotherapy

19 Sep 2017

Therapeutic care (TC) appears to improve anxiety and depression and reduce fatigue in breast cancer patients undergoing chemotherapy, a new clinical trial has shown.

Investigators randomly divided 48 breast cancer patients into two groups: those who were given TC (intervention group; n=24) and those who were not (control group; n=24). Patients who were pregnant, had psychiatric illnesses or took supplements for fatigue were excluded.

TC was delivered as acupressure at select pressure points. Sessions lasted 30 minutes per day and delivered three days a week, with each point receiving 10 minutes of pressure time. The entire regimen lasted 12 weeks.

General fatigue was significantly alleviated in the patients who received TC compared to those who received sham at both 6 (mean difference [MD], -2.0; 95 percent CI, -2.8 to -1.7; p<0.01) and 12 (MD, -3.1; -3.9 to -2.3; p<0.01) weeks of intervention.

There were no significant differences in the Hospital Anxiety and Depression (HADS) and Pittsburgh Sleep Quality Index (PSQI) scores between the intervention and control groups at week 6.

In contrast, HADS-anxiety (MD, -1.5; -2.1 to -0.9; p<0.01), HADS-depression (MD, -1.8; -2.6 to -1.2; p<0.01) and PSQI (MD, -1.6; -2.2 to -1.0; p<0.01) scores were significantly better in the intervention group at 12 weeks.

Physical and mental fatigue were also significantly reduced in the intervention group than in the control group at 6 (p<0.01 and p<0.05, respectively) and 12 (p<0.01 for both) weeks.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.